Your browser doesn't support javascript.
loading
Influenza versus other respiratory viruses - assessing severity among hospitalised children, Belgium, 2011 to 2020.
Fischer, Natalie; Moreels, Sarah; Dauby, Nicolas; Reynders, Marijke; Petit, Evelyn; Gérard, Michèle; Lacor, Patrick; Daelemans, Siel; Lissoir, Bénédicte; Holemans, Xavier; Magerman, Koen; Jouck, Door; Bourgeois, Marc; Delaere, Bénédicte; Quoilin, Sophie; Van Gucht, Steven; Thomas, Isabelle; Bossuyt, Nathalie; Barbezange, Cyril.
Afiliação
  • Fischer N; National Influenza Centre, Sciensano, Brussels, Belgium.
  • Moreels S; European Public Health Microbiology Training Programme (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Dauby N; Health Services Research - Epidemiology and Public Health, Sciensano, Brussels, Belgium.
  • Reynders M; Centre for Environmental Health and Occupational Health, School of Public Health, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Petit E; Centre Hospitalier Universitaire St-Pierre, Brussels, Belgium.
  • Gérard M; Department of Laboratory Medicine, Medical Microbiology, Algemeen Ziekenhuis Sint-Jan, Brugge-Oostende AV, Belgium.
  • Lacor P; Department of Laboratory Medicine, Medical Microbiology, Algemeen Ziekenhuis Sint-Jan, Brugge-Oostende AV, Belgium.
  • Daelemans S; Centre for Environmental Health and Occupational Health, School of Public Health, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Lissoir B; Internal Medicine-Infectious Diseases, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Holemans X; Paediatric Pulmonary and Infectious Diseases, Universitair Ziekenhuis Brussel, Brussels, Belgium.
  • Magerman K; Microbiology, Grand Hôpital de Charleroi, Charleroi, Belgium.
  • Jouck D; General Internal Medicine and Infectiology, Grand Hôpital de Charleroi, Charleroi, Belgium.
  • Bourgeois M; Clinical Laboratory, Jessa Ziekenhuis, Hasselt, Belgium.
  • Delaere B; Infection Control, Jessa Ziekenhuis, Hasselt, Belgium.
  • Quoilin S; Infection Control, Jessa Ziekenhuis, Hasselt, Belgium.
  • Van Gucht S; Centre Hospitalier Universitaire UCL Namur, Yvoir, Belgium.
  • Thomas I; Centre Hospitalier Universitaire UCL Namur, Yvoir, Belgium.
  • Bossuyt N; Epidemiology of Infectious Diseases - Epidemiology and Public Health, Sciensano, Brussels, Belgium.
  • Barbezange C; National Influenza Centre, Sciensano, Brussels, Belgium.
Euro Surveill ; 28(29)2023 07.
Article em En | MEDLINE | ID: mdl-37470740
ABSTRACT
BackgroundKnowledge on the burden attributed to influenza viruses vs other respiratory viruses in children hospitalised with severe acute respiratory infections (SARI) in Belgium is limited.AimThis observational study aimed at describing the epidemiology and assessing risk factors for severe disease.MethodsWe retrospectively analysed data from routine national sentinel SARI surveillance in Belgium. Respiratory specimens collected during winter seasons 2011 to 2020 were tested by multiplex real-time quantitative PCR (RT-qPCR) for influenza and other respiratory viruses. Demographic data and risk factors were collected through questionnaires. Patients were followed-up for complications or death during hospital stay. Analysis focused on children younger than 15 years. Binomial logistic regression was used to identify risk factors for severe disease in relation to infection status.ResultsDuring the winter seasons 2011 to 2020, 2,944 specimens met the study case definition. Complications were more common in children with underlying risk factors, especially asthma (adjusted risk ratio (aRR) 1.87; 95% confidence interval (CI) 1.46-2.30) and chronic respiratory disease (aRR 1.88; 95% CI 1.44-2.32), regardless of infection status and age. Children infected with non-influenza respiratory viruses had a 32% higher risk of complications (aRR 1.32; 95% CI 1.06-1.66) compared with children with influenza only.ConclusionMulti-virus testing in children with SARI allows a more accurate assessment of the risk of complications and attribution of burden to respiratory viruses beyond influenza. Children with asthma and respiratory disease should be prioritised for clinical care, regardless of their virological test result and age, and targeted for prevention campaigns.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Infecções Respiratórias / Asma / Vírus / Influenza Humana Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans / Infant País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Infecções Respiratórias / Asma / Vírus / Influenza Humana Tipo de estudo: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans / Infant País/Região como assunto: Europa Idioma: En Revista: Euro Surveill Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bélgica